CONNECT WITH US
Tech

Tech

Samsung's Galaxy Ring gets FDA approval for advanced sleep apnea detection

Engadget logo

Published on

Add as a preferred source on Google
Samsung's Galaxy Ring gets FDA approval for advanced sleep apnea detection

The upgraded feature uses AI to detect the number of breathing disruptions for every hour you sleep.

Samsung's Galaxy Ring now offers more advanced sleep apnea detection following FDA approval of the new feature in July, the company announced. The feature may give users new clues about why they feel exhausted even after sleeping through the night.

Samsung first received so-called De Novo FDA authorization for sleep apnea detection on its Galaxy Watch and Galaxy Ring devices back in February 2024. (De Novo is used for health products or features that have never been on the market before and don't pose any danger to a user's health.) The original approval only covered detection for symptoms of moderate to severe sleep apnea.

The new version does that, but also uses AI to detect the frequency of breathing disruptions for every hour you sleep. Provided you sleep at least five hours for two nights over a ten-day period, Samsung's Health Monitor app can tell you if you have mild, occasional or frequent sleep apnea. Samsung points out that only a physician can do a proper sleep apnea diagnosis, but the device "can lead to productive conversations with healthcare professionals."

Neither of Samsung's primary Galaxy Ring competitors, Oura and Superhuman, offer FDA-approved sleep apnea detection. However, both can track nighttime disturbances that may indicate signs of the condition. Samsung and Oura are currently locked in a legal dispute over smart ring patents, with a preliminary decision expected to be handed down soon .


Source link
Related Topics:Tech

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.